Introduction
There are not enough doctors to treat people with untreated epilepsy so if the epilepsy treatment gap in the developing world is to be closed then other health professionals must be involved with epilepsy management. 1 To do this they will need help. The diagnosis of episodes of altered consciousness as epileptic seizures is one important part of the management of epilepsy. This is traditionally done by doctors and is relatively time-consuming. It relies on asking questions and interpreting the replies, a process which is no different in the developing world than in the industrialised one. 2 It should be possible to design a tool to do this using a Bayesian approach, which mirrors the clinical diagnostic process. This would enable the diagnosis to be made by non-doctors and save precious medical time. The information necessary to develop this tool was available to us from a previous study from Nepal in which we trained non-neurologists to diagnose epilepsy.
Purpose:
The epilepsy treatment gap in resource-poor countries is so large that existing numbers of doctors are unlikely to be able to close it. Other health workers are likely to be needed but they will need help. The diagnosis of an attack as epileptic or not is an essential step in the management of epilepsy. It should be possible to devise a tool to give the probability of episodes being epileptic based on a Bayesian analysis of the results of history taking. 
Epilepsy camps
A visiting neurologist (VP) performed special clinics for people with suspected epilepsy at both the hospital and some of these outreach centres. These camps were advertised as widely as possible during the preceding weeks using local notices, newspapers, local radio and word-of-mouth.
Initial consultation model
The neurologist was accompanied by a local physician (PP), and an intern doctor (NG) who acted as interpreters, translating the history from Nepali into English for VP. If epilepsy was possible then predetermined questions were asked about the nature of the episodes. 3 These questions were grouped around broad themes:
demography, events preceding the episode, eyewitness description of the episode when available, events following the episode and predisposing factors (Table 1) .
Patients and clinical diagnosis
Children under nine years old were excluded because of the possibility of significant differences in clinical seizure presentation in younger children. At the end of the history, the neurologist made a clinical diagnosis of the presenting episodes which was expressed as epileptic seizures (ES), not epileptic seizures (NES), single seizure or uncertain.
For the rest of the analysis the last two categories were excluded.
Likelihood ratios
For each variable the likelihood of having epileptic seizures (ES) and not having epileptic seizures (NES) was calculated as a likelihood ratio (LR). 4 The variables with the most significant LRs were then selected for the validation phase.
Validation
This was carried out on a different population of patients but at the same locations. The diagnosis of ES, NES or uncertainty was again made by the neurologist on clinical grounds. During the course of history taking the answers to each of the previously selected questions was entered on a spreadsheet by the translating intern (AB) and a final probability score of ES obtained. The neurologist was not aware of this probability until he had reached his own clinical diagnosis.
Results

Pre-test probability
A total of 72 patients were seen. Five were excluded from analysis, three because the diagnosis was uncertain and two who had single seizures. This left a study population of 67.
Fifty-one of these had ES and 16 NES giving a pre-test probability of having ES of 0.76. The most common diagnosis in those patients with NES was non-epileptic attack disorder. Fortyseven of those with ES had convulsive (tonic-clonic) seizures and four had non-convulsive (partial) seizures only.
Likelihood ratios
The LR for the episodes either being ES or NES based on the presence or absence of a variable was then calculated for each variable. If, in calculating the LR, a zero value in the denominator was encountered, this was dealt with by adding 1 to that one value rather than adding 0.5 to each value in the 2 Â 2 table as in the correction devised by Cox. 5 This had a conservative effect on the size of LRs.
Relevant answers
The reciprocal was taken of those LRs less than one (in favour of NES) to compare the magnitude of the effect of each LR. In this way eleven questions had a magnitude greater than three and were then selected for further evaluation. These are shown in Table 2 .
Development of a Bayesian model
The relevant questions were ordered on a logical basis for history taking with gender and predisposing factors first, then events in the attack and finally post-ictal weakness. The pre-test probability of 0.76 was altered by the LR for gender to give a posttest probability. This then became the pre-test probability for the next question, predisposing factors, resulting in a post-test probability. This process was repeated for the remaining nine questions after which a final probability score for that person having ES was obtained. 
Validation in a different population
Fourteen people made up this population. The clinical diagnosis of ES was made in 10, NES in three and in one the diagnosis was uncertain. Of those with ES, eight were convulsive and two nonconvulsive -one with head turning and asymmetric limb posturing and the other with running. These had probability scores of ES of 0.89 and 0.88 respectively.
For ES the mean probability was 0.97, range 0.88-1.0. For NES mean was 0.3, range 0.07-0.42. The clinically uncertain case had a probability of 1.0. Probability scores are plotted for each clinical diagnosis in Fig. 1 .
Discussion
It is therefore possible to design a tool to diagnose episodes of altered consciousness as epileptic or not. This tool is based on Bayesian principles and mirrors the way in which physicians make the diagnosis of epilepsy except that they do it intuitively based on their previous experience. Their advantage over a tool is being able to access a range of contextual information and non-verbal communication in coming to their conclusion but with the disadvantage of sometimes bringing their own emotions into the diagnosis -for example, being reluctant to classify an attack as epileptic because they know that this would have a much more drastic effect on someone whose occupation depends on driving a vehicle than a non-epileptic diagnosis would. This tool is devoid of such emotion. It is based simply on the acquired and recorded experience gleaned from 67 people with episodic alteration or loss of consciousness; most neurologists will have seen, considerably more patients than this, but health workers who are the first (and sometimes the only) point of contact for people with epilepsy in much of the world will have seen less. It is for these people that we have developed this tool although it may well be useful for lessexperienced doctors.
Using 11 eloquent variables avoids the overdependence on single symptoms, none of which is invariably correct in making or excluding a diagnosis of an epileptic seizure. It also lessens the effect of the intrinsic unreliability present in giving a history of remote events.
A similar approach has been used to separate syncope from epilepsy. 6 This was developed in tertiary referral clinics in resource-rich countries and is unlikely to be relevant to presentations in the resource-poor world. Perhaps the most surprising inclusion in the tool was being male with an LR of 9.73. This was due to the presence of nonepileptic attack disorder within the group of people whose attacks were NES, almost all of them female.
Although the tool was validated in only 14 people the separation between ES and NES was very clear. Importantly the two people with partial (non-convulsive) seizures had high probabilities of epilepsy. Forty-seven of our 51 patients on whom the tool was developed had convulsive (tonic-clonic) seizures, in common with seizures patterns throughout the less-developed world, so it was encouraging that these non-convulsive seizures had probabilities much closer to ES than NES.
The gold-standard in epilepsy diagnosis is the opinion of a neurologist. In this case having more than one neurologist was not possible. All we can say to suggest a probable high degree of accuracy is that the neurologist (VP) has had over 30 years experience in a busy neurological practice in the UK health service, has developed epilepsy services within that, has contributed to multicentre studies on epilepsy management and is a member of the International League Against Epilepsy's Faculty of 1000.
The tool has been developed and tested in one region of one resource-poor country and there may be differences in how epileptic attacks present or are described in other parts of the resource-poor world and certainly in the developed world. There may also be different pre-test probabilities in different parts of the world and a different spectrum of conditions contributing to NES. Of the variables in the tool, only colour change to red or blue may not be easily transferable to regions with very dark skin colours.
Another possible shortcoming is unwitting interdependence of the variables used in the tool. This is certainly not obvious but Bayes theorem requires that the variables tested are truly independent of each other. 7 So clearly this tool must be evaluated in other areas where the epilepsy treatment gap is large. This is underway with the tool embedded in a mobile phone app.
